JRCT ID: jRCT2080225355
Registered date:26/08/2020
Basic Information
Recruitment status | completed |
---|---|
Health condition(s) or Problem(s) studied | |
Date of first enrollment | 01/06/2020 |
Target sample size | 159 |
Countries of recruitment | Japan,North America,Europe,Oceania |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : INN of investigational material : dersimelagon Therapeutic category code : 269 Other agents for epidermis Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : --- Other Dosage and Administration for Investigational material : |
Outcome(s)
Primary Outcome | efficacy |
---|---|
Secondary Outcome | efficacy efficacy efficacy efficacy efficacy |
Key inclusion & exclusion criteria
Age minimum | >= 12age old |
---|---|
Age maximum | <= 75age old |
Gender | Both |
Include criteria | |
Exclude criteria |
Related Information
Primary Sponsor | |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | NCT04402489,2019-004226-16,JapicCTI-205451 |
Contact
Public contact | |
Name | |
Address | |
Telephone | |
cti-inq-ml@ml.mt-pharma.co.jp | |
Affiliation | |
Scientific contact | |
Name | |
Address | |
Telephone | |
cti-inq-ml@ml.mt-pharma.co.jp | |
Affiliation |